Lonza | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Akzo Nobel EUR 1.6B 297M 2025-03
Alcon AG USD 1.41B 417M 2025-03
Almirall EUR 377.1M 47.69M 2024-12
AstraZeneca USD 5.23B 258M 2025-03
BASF EUR 2.31B 600M 2025-03
Bayer EUR 4.02B 2.18B 2025-03
Beiersdorf EUR 1.21B 7M 2024-12
Covestro EUR 742M 233M 2025-03
Demant 1.11B 64M 2024-12
Fresenius EUR 2.39B 105M 2025-03
Fresenius Medical Care EUR 1.07B 109M 2025-03
Geberit CHF 403.6M 4.1M 2025-03
Genmab DKK 1.62B 8.24B 2025-03
Givaudan CHF 603M 3M 2024-06
GlaxoSmithKline GBP 4.46B 594M 2025-03
GN Store Nord DKK 787M 99M 2025-03
Hikma Pharmaceutical USD 0 1000K 2024-06
Johnson Matthey GBP 898M 277M 2025-03
Merck EUR 2.15B 1.01B 2024-12
Novartis USD 8.87B 4.74B 2024-12
Philips EUR 1.19B 1.21B 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 7.99B 550M 2025-03
Sika AG CHF 707.5M 59.3M 2024-12
Smith & Nephew 568M 266M 2024-06
Solvay EUR 451M 88M 2025-03
UCB EUR 1.57B 1.14B 2024-12



Lonza Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.